MARKET

ATRS

ATRS

Antares Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.015
+0.015
+0.50%
Opening 13:23 08/13 EDT
OPEN
2.970
PREV CLOSE
3.000
HIGH
3.040
LOW
2.959
VOLUME
291.52K
TURNOVER
--
52 WEEK HIGH
5.13
52 WEEK LOW
1.600
MARKET CAP
500.77M
P/E (TTM)
90.27
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ATRS stock price target is 6.25 with a high estimate of 8.00 and a low estimate of 4.500.

EPS

ATRS News

More
Antares Pharma Appoints Tram Bui as Vice President of Corporate Communications and Investor Relations
GlobeNewswire · 3d ago
A Quick Analysis On Antares Pharma's (NASDAQ:ATRS) CEO Compensation
Simply Wall St. · 6d ago
Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 6d ago
Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance
GlobeNewswire · 08/06 12:00
Why Antares Pharma's Stock Is Trading Higher Today
Antares Pharma (NASDAQ: ATRS) shares are trading higher on Monday after the company announced a deal with Lunatus Global to distribute and promote XYOSTED in Saudi Arabia.
Benzinga · 08/03 19:52
Antares Pharma shares are trading higher after the company announced a deal with Lunatus Global to distribute and promote XYOSTED in Saudi Arabia.
Benzinga · 08/03 18:50
Did Hedge Funds Make The Right Call On Antares Pharma Inc (ATRS)?
Insider Monkey · 08/03 15:55
Antares Pharma and Lunatus Enter Into an Exclusive Distribution Agreement for XYOSTED® in Saudi Arabia and the United Arab Emirates
GlobeNewswire · 08/03 12:00

Industry

Medical Equipment, Supplies & Distribution
+0.57%
Healthcare Equipment & Supplies
+0.64%

Hot Stocks

Symbol
Price
%Change

About ATRS

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.
More

Webull offers kinds of Antares Pharma Inc stock information, including NASDAQ:ATRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATRS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ATRS stock methods without spending real money on the virtual paper trading platform.